Navigation Links
Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment
Date:4/30/2009

NEW YORK and NASSAU, The Bahamas, April 30 /PRNewswire-FirstCall/ -- Prospero Group (PRPG) invested into the Private Placement Plan of Fincor (FINC) through a 1:1 share split. Prospero Group a leading company in the field of Water Technologies enlarges thru Fincor its portfolio with the new ACTRx Malaria and Dengue fever treatment. Fincor also acquired the WETTECH and Advanced Cavitation Technologies.

Prospero Group enlarges its technology portfolio with ACTRx, which combines several natural drugs to fight Malaria and Dengue fever. Prospero Group's largest shareholder, Fincor acquired a majority on ACTRx International Inc. to become the premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services.

Both Malaria and Dengue fever appear in the human landscape and seem to have only nebulous solutions that work sporadically in over one half of the countries in the world. Yet there are countries that have enjoyed the disappearance of both of these mosquito born diseases. Prospero Group's intention is to research, review and objectively resolve the issues that keep these diseases active in our global society.

Fincor also acquired WETTECH marketed as Prospero Water Technologies and the Advanced Cavitation Technology.

Prospero Group intends to make further strategic acquisitions of proven, reliable and innovative technologies to its portfolio.

It was decided by the Board Members of Prospero Group on Friday, April 24, 2009 to invest into the Private Placement Plan of Fincor Inc. through a 1:1 share split of Prospero Group shareholdings.

About Prospero Group: Prospero Group is a U.S. and Bahamian technology development company whose primary focus is developing and producing technologies for potable water and alternative energy systems. Our market developments are concentrated
'/>"/>

SOURCE Prospero Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International Coal Group Is Lead Sponsor for West Virginia Susan G. Komen Race For The Cure
2. Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for Americas Health
3. Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity
4. Unsung Heroes of Health Care Reform?: $36 Billion in Annual Savings Linked to Group Purchasing Organizations in Major Survey of Over 400 Hospitals
5. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
6. Salmon of the Americas Responds to PEW Environmental Group
7. Less Than a Year After CDC Announced the U.S. HIV Epidemic Is Much Larger Than Previously Thought, Publics Sense of Urgency Is Down, Even Among Some Higher Risk Groups
8. Guidelines for medical home demonstrations released by major physician groups
9. The Quantum Group Announces Filing of Utility Patent Application
10. Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
11. New Report by BioTrends Research Group to Highlight the Launch of SIMPONI(R) (golimumab)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
(Date:4/17/2014)... and their partners have found that their proprietary microbicide ... of multiple sexually transmitted infections (STIs) in both the ... 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded study ... effective against multiple strains of HIV, and has a ... viruses of at least eight hours prior to exposure. ...
Breaking Medicine News(10 mins):Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... of the University of Pennsylvania reported today that students ... activity are less likely to smoke than their classmates. ... participation extends at least three years beyond graduation. The ... the same level of protection from school sports as ...
... SATELLITE FEED: ... 6:30 PM - 6:45 PM ET ... C-Band ... Downlink Freq: 3980 Horizontal NEWS: Football Legend John Madden ...
... Created by Hospitals from Around the Country Appeal to the ... Contest to Win a Free MRI, MALVERN, Pa., Dec. 6 ... community, but can,t seem to find the time,now,s your chance to ... click of your mouse! The video posting period in Siemens first-ever,"Win ...
... SAN DIEGO, Dec. 6 Neurocrine Biosciences,Inc. (Nasdaq: ... has closed its sale,and leaseback agreement with Veralliance ... by Neurocrine for the properties was,$109 million. Concurrently ... its corporate headquarters for a 12 year term, ...
... on Christmas ... harmony, CINCINNATI, Dec. 6 As they,re searching the ... toys they,think are safe, now parents have a new worry: ... because the unsafe toy they wanted,isn,t under the tree., ...
... Dec. 6 Dr. Belinda Tsao-Nivaggioli,Chief Executive Officer ... http://www.avicenagroup.com ) will be featured in an exclusive ... at 5 p.m. EST. The interview,will be posted ... on December 10., The interview will cover ...
Cached Medicine News:Health News:Participation in organized high school activities lowers risk of smoking 3 years after graduation 2Health News:Participation in organized high school activities lowers risk of smoking 3 years after graduation 3Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 2Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 3Health News:Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets 2Health News:Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents 2Health News:Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents 3Health News:WallSt.net Announces Upcoming Interview With CEO of Avicena Group 2
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading innovation ... Leadership Summit , May 14-16, 2014 at the Global ... . This is the premier ... breakthrough achievements through open innovation. Participants will learn how ...
(Date:1/14/2014)... PORT WASHINGTON, New York , January 14, ... the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... sales growth for the fourth straight year.   ... of exposure for pharmacy technicians, pharmacists, nurses and ...
(Date:1/14/2014)... FRANCISCO , Jan. 14, 2014 Spark Therapeutics , ... for its most advanced clinical program, a Phase 3 study for ... gene. Spark,s CEO, Jeffrey D. Marrazzo , is presenting this ... Healthcare Conference in San Francisco . Marrazzo said ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... officials in FDA,s Office of New Drugs (OND), the ... a cardiovascular outcomes trial (CVOT) for Contrave® that would ... 2011. Orexigen believes that these design requirements are reasonable ...
... CLEVELAND, Sept. 20, 2011 Dr. Melisa Estes, who is ... suffer from chronic knee pain. She recently began incorporating a ... nerve stimulation, also known as TENS, sends electrical stimulation to ... signals from reaching the brain, and that reduces pain. ...
Cached Medicine Technology:Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 2Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 3Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 4Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 5Knee Pain Control - No Drugs - Doctor Used 2
The Panorama Central Station includes bi-directional communication with Datascope bedside monitors, optional 72 hours of disclosure and a touch screen user interface....
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
Developed in a Microsoft Windows environment, MedInformatix provides physician practices a Computerized Patient Record (CPR) with a Practice Management System (PMS) that is both integrated and design...
Medicine Products: